NCT05662813 2022-12-23
Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy
West China Hospital
Phase 2 Unknown
Clinical Trials
14 trialsNCT04825470 2022-03-11
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
Phase NA Unknown
NCT04640116 2020-12-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
Phase NA Unknown
NCT03811431 2019-01-22
ConCLUDe
Iuliu Hatieganu University of Medicine and Pharmacy
Phase NA Unknown
NCT03620916 2018-10-04
Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver Resection
Medical University of Warsaw
Phase NA Unknown
NCT03357978 2017-11-30
Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia
Johann Wolfgang Goethe University Hospital
Phase NA Unknown
NCT02208804 2016-11-09
SIM
UMC Utrecht
Phase 2/3 Unknown
NCT02758977 2016-05-03
ALPPSforCRLM
University of Zurich
Phase NA Unknown
NCT01567631 2016-02-01
LAHIGA
Southwest Hospital, China
Phase NA Unknown
NCT02647047 2016-01-06
Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery
Ospedale San Raffaele
Phase NA Unknown
NCT02074202 2014-02-28
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 3 Unknown
NCT01423708 2012-07-18
EPOCAL
Azienda Ospedaliera di Padova
Phase 2 Unknown
NCT01556815 2012-04-25
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT01533324 2012-02-15
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)
Second Military Medical University
Phase 2 Unknown